Global Health Impact Fund (GHIF) is a clinician-led venture capital firm investing in early-stage healthcare startups. They leverage a network of over 2,000 clinicians to identify and support innovations that are clinically relevant and poised for real-world adoption, focusing on improving patient outcomes and healthcare delivery efficiency.
About Global Health Impact Fund
Global Health Impact Fund is a healthcare-focused investment vehicle with a public-mission orientation, suggested by the name and the globalhealthimpactfund.com website to focus on global health, equity, and impact-oriented healthcare investing. The publicly available materials do not surface specific stages, check sizes, geographic focus, or AI thesis details. For healthcare AI founders, this is a thesis-aligned match only if your business addresses global health challenges: AI tools for low-resource settings, infectious disease surveillance, maternal and child health in emerging markets, or affordable diagnostics designed for under-served populations. Founders building US-only commercial healthcare AI should look elsewhere; the impact mandate privileges global health equity and underserved populations. Plausible check sizes for impact-oriented health funds of this profile run 250K to 2M, often blended with grant funding or concessional capital alongside commercial returns expectations. Entry path is LinkedIn outreach to fund leadership with a clear global health framing, or warm introduction through global health policy networks, WHO-affiliated organizations, USAID and Gates Foundation grantees, or impact investing communities. Founders should approach with a sharp impact thesis: which population, what health outcomes you are improving, what evidence base you have, and how your unit economics work in low-income contexts. Diligence will likely include impact measurement frameworks alongside financial diligence; founders should be prepared to articulate health outcomes data, not just technology metrics. Treat this as a specialist conversation that complements rather than replaces commercial venture capital. Realistic expectation is that the fund leads or co-leads small rounds and offers strong global health network access, not Silicon Valley scaling capital.
Founder reviews
Healthcare AI tools backed by Global Health Impact Fund
Tools made by companies in Global Health Impact Fund's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in Global Health Impact Fund's portfolio not currently in our directory.
- Elemeno Health
- Uberdoc
- Elucid
- Plethy
- GHIN
- Raydiant Oximetry
- Handzin
- Somnoware
Team
Pitch / review this investor
Have you raised from Global Health Impact Fund? Founders only — share your honest experience (anonymous OK, moderated before publishing).